Dynamic regulation of inter-organelle communication by ubiquitylation controls skeletal muscle development and disease onset

  1. Arian Mansur
  2. Remi Joseph
  3. Euri Kim
  4. Pierre M Jean-Beltran
  5. Namrata D Udeshi
  6. Cadence Pearce
  7. Hanjie Jiang
  8. Reina Iwase
  9. Miroslav P Milev
  10. Hashem A Almousa
  11. Elyshia McNamara
  12. Jeffrey Widrick
  13. Claudio Perez
  14. Gianina Ravenscroft
  15. Michael Sacher
  16. Philip A Cole
  17. Steven A Carr
  18. Vandana A Gupta  Is a corresponding author
  1. Brigham and Women's Hospital, United States
  2. Broad Institute, United States
  3. Concordia University of Edmonton, Canada
  4. University of Western Australia, Australia
  5. Boston Children's Hospital, United States

Abstract

Ubiquitin-proteasome system (UPS) dysfunction is associated with the pathology of a wide range of human diseases, including myopathies and muscular atrophy. However, the mechanistic understanding of specific components of the regulation of protein turnover during development and disease progression in skeletal muscle is unclear. Mutations in KLHL40, an E3 ubiquitin ligase cullin3 (CUL3) substrate-specific adapter protein, result in severe congenital nemaline myopathy, but the events that initiate the pathology and the mechanism through which it becomes pervasive remain poorly understood. To characterize the KLHL40-regulated ubiquitin-modified proteome during skeletal muscle development and disease onset, we used global, quantitative mass spectrometry-based ubiquitylome and global proteome analyses of klhl40a mutant zebrafish during disease progression. Global proteomics during skeletal muscle development revealed extensive remodeling of functional modules linked with sarcomere formation, energy, biosynthetic metabolic processes, and vesicle trafficking. Combined analysis of klh40 mutant muscle proteome and ubiquitylome identified thin filament proteins, metabolic enzymes, and ER-Golgi vesicle trafficking pathway proteins regulated by ubiquitylation during muscle development. Our studies identified a role for KLHL40 as a regulator of ER-Golgi anterograde trafficking through ubiquitin-mediated protein degradation of secretion-associated Ras-related GTPase1a (Sar1a). In KLHL40 deficient muscle, defects in ER exit site vesicle formation and downstream transport of extracellular cargo proteins result in structural and functional abnormalities. Our work reveals that the muscle proteome is dynamically fine-tuned by ubiquitylation to regulate skeletal muscle development and uncovers new disease mechanisms for therapeutic development in patients.

Data availability

The data is publicly available via Sequence Read Archive (SRA) (Accession Number: PRJNA861969) and MassIVE (http://massive.ucsd.edu) and are accessible at ftp://MSV000090018@massive.ucsd.edu.

The following data sets were generated

Article and author information

Author details

  1. Arian Mansur

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Remi Joseph

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Euri Kim

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Pierre M Jean-Beltran

    Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5106-0992
  5. Namrata D Udeshi

    Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Cadence Pearce

    Proteomics Platform, Broad Institute, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Hanjie Jiang

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Reina Iwase

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3703-2511
  9. Miroslav P Milev

    Department of Biology, Concordia University of Edmonton, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Hashem A Almousa

    Department of Biology, Concordia University of Edmonton, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Elyshia McNamara

    Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  12. Jeffrey Widrick

    Division of Genetics, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Claudio Perez

    Department of Anesthesiology, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Gianina Ravenscroft

    Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Michael Sacher

    Department of Biology, Concordia University of Edmonton, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  16. Philip A Cole

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6873-7824
  17. Steven A Carr

    Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Vandana A Gupta

    Department of Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    vgupta@research.bwh.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4057-8451

Funding

A foundation Building Strength

  • Vandana A Gupta

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R56AR077017)

  • Vandana A Gupta

National Institute of Health (R37GM62437)

  • Philip A Cole

National Cancer Institute (R01CA74305)

  • Philip A Cole

Brigham and Women's Hospital

  • Vandana A Gupta

National Heart, Lung, and Blood Institute (F32HL154711)

  • Pierre M Jean-Beltran

National Health and Medical Research Council (APP2002640)

  • Gianina Ravenscroft

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Meir Aridor

Ethics

Animal experimentation: Zebrafish were maintained and bred using standard methods as described (Westerfield,2000). All experiments and procedures were approved by the Institutional Animal Care and Use Committee at Brigham and Women's Hospital. (2016000304).

Human subjects: Human Research Ethics Committee of the University of Western Australia (RA/4/20/1008). Written informed consent was provided by all families.

Version history

  1. Received: July 18, 2022
  2. Preprint posted: July 22, 2022 (view preprint)
  3. Accepted: June 16, 2023
  4. Accepted Manuscript published: July 11, 2023 (version 1)
  5. Version of Record published: July 19, 2023 (version 2)

Copyright

© 2023, Mansur et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 947
    views
  • 157
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Arian Mansur
  2. Remi Joseph
  3. Euri Kim
  4. Pierre M Jean-Beltran
  5. Namrata D Udeshi
  6. Cadence Pearce
  7. Hanjie Jiang
  8. Reina Iwase
  9. Miroslav P Milev
  10. Hashem A Almousa
  11. Elyshia McNamara
  12. Jeffrey Widrick
  13. Claudio Perez
  14. Gianina Ravenscroft
  15. Michael Sacher
  16. Philip A Cole
  17. Steven A Carr
  18. Vandana A Gupta
(2023)
Dynamic regulation of inter-organelle communication by ubiquitylation controls skeletal muscle development and disease onset
eLife 12:e81966.
https://doi.org/10.7554/eLife.81966

Share this article

https://doi.org/10.7554/eLife.81966

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Christopher TA Lewis, Elise G Melhedegaard ... Julien Ochala
    Research Article

    Hibernation is a period of metabolic suppression utilized by many small and large mammal species to survive during winter periods. As the underlying cellular and molecular mechanisms remain incompletely understood, our study aimed to determine whether skeletal muscle myosin and its metabolic efficiency undergo alterations during hibernation to optimize energy utilization. We isolated muscle fibers from small hibernators, Ictidomys tridecemlineatus and Eliomys quercinus and larger hibernators, Ursus arctos and Ursus americanus. We then conducted loaded Mant-ATP chase experiments alongside X-ray diffraction to measure resting myosin dynamics and its ATP demand. In parallel, we performed multiple proteomics analyses. Our results showed a preservation of myosin structure in U. arctos and U. americanus during hibernation, whilst in I. tridecemlineatus and E. quercinus, changes in myosin metabolic states during torpor unexpectedly led to higher levels in energy expenditure of type II, fast-twitch muscle fibers at ambient lab temperatures (20 °C). Upon repeating loaded Mant-ATP chase experiments at 8 °C (near the body temperature of torpid animals), we found that myosin ATP consumption in type II muscle fibers was reduced by 77–107% during torpor compared to active periods. Additionally, we observed Myh2 hyper-phosphorylation during torpor in I. tridecemilineatus, which was predicted to stabilize the myosin molecule. This may act as a potential molecular mechanism mitigating myosin-associated increases in skeletal muscle energy expenditure during periods of torpor in response to cold exposure. Altogether, we demonstrate that resting myosin is altered in hibernating mammals, contributing to significant changes to the ATP consumption of skeletal muscle. Additionally, we observe that it is further altered in response to cold exposure and highlight myosin as a potentially contributor to skeletal muscle non-shivering thermogenesis.

    1. Cell Biology
    Jun Yang, Shitian Zou ... Xiaochun Bai
    Research Article

    Quiescence (G0) maintenance and exit are crucial for tissue homeostasis and regeneration in mammals. Here, we show that methyl-CpG binding protein 2 (Mecp2) expression is cell cycle-dependent and negatively regulates quiescence exit in cultured cells and in an injury-induced liver regeneration mouse model. Specifically, acute reduction of Mecp2 is required for efficient quiescence exit as deletion of Mecp2 accelerates, while overexpression of Mecp2 delays quiescence exit, and forced expression of Mecp2 after Mecp2 conditional knockout rescues cell cycle reentry. The E3 ligase Nedd4 mediates the ubiquitination and degradation of Mecp2, and thus facilitates quiescence exit. A genome-wide study uncovered the dual role of Mecp2 in preventing quiescence exit by transcriptionally activating metabolic genes while repressing proliferation-associated genes. Particularly disruption of two nuclear receptors, Rara or Nr1h3, accelerates quiescence exit, mimicking the Mecp2 depletion phenotype. Our studies unravel a previously unrecognized role for Mecp2 as an essential regulator of quiescence exit and tissue regeneration.